Day One Biopharmaceuticals Inc (DAWN)
13.72
+0.38
(+2.85%)
USD |
NASDAQ |
Nov 22, 16:00
15.14
+1.42
(+10.35%)
After-Hours: 20:00
Day One Biopharmaceuticals Revenue (Quarterly): 93.76M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 93.76M |
Date | Value |
---|---|
June 30, 2024 | 8.192M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
8.192M
Minimum
Jun 2024
93.76M
Maximum
Sep 2024
50.98M
Average
50.98M
Median
Revenue (Quarterly) Benchmarks
Perspective Therapeutics Inc | -- |
Electromed Inc | 14.67M |
Xtant Medical Holdings Inc | 27.94M |
Myomo Inc | 9.208M |
Catheter Precision Inc | 0.096M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | 37.04M |
Total Expenses (Quarterly) | 64.12M |
EPS Diluted (Quarterly) | 0.38 |
Enterprise Value | 825.23M |
Gross Profit Margin (Quarterly) | 98.30% |
Profit Margin (Quarterly) | 39.50% |
Earnings Yield | -7.51% |